PreprintAll rights reservedbioRxiv
A low-androgen environment sustains redox-active sGC states required to restrain castration-resistant prostate cancer growth via elevated cGMP levels
- 1University of Miami Miller School of Medicine
Related
- Prediction models for progression to castration-resistant prostate cancer after androgen deprivation therapy: a narrative review (2021–2026)
- Bipolar androgen therapy in castration-resistant prostate cancer: Biological rationale, clinical evidence, and future directions.
- An Immunocompetent Mouse Model of Degarelix Induced Chemical Castration to Investigate Acquired Resistance to Androgen Deprivation.
- 427 Eomes sustains progenitor exhausted CD8 T-cell differentiation required for optimal response to immune checkpoint blockade in melanoma
- Real‐World Overall Survival With Abiraterone Acetate and Enzalutamide in Patients With Chemotherapy‐Naïve Metastatic Castration‐Resistant Prostate Cancer From the Flatiron Electronic Health Records Database
BibTeX
@misc{troccoli2026lowandrogen,
title = {{A low-androgen environment sustains redox-active sGC states required to restrain castration-resistant prostate cancer growth via elevated cGMP levels}},
author = {C. I. Troccoli and B. Mateo-Victoriano and A. Beuve and M. Jorda and J. Sharma and P. Rai},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.12.753798},
url = {https://www.biorxiv.org/content/10.64898/2026.10.12.753798v1},
}
RIS
TY - UNPB
TI - A low-androgen environment sustains redox-active sGC states required to restrain castration-resistant prostate cancer growth via elevated cGMP levels
AU - C. I. Troccoli
AU - B. Mateo-Victoriano
AU - A. Beuve
AU - M. Jorda
AU - J. Sharma
AU - P. Rai
PY - 2026
DA - 2026/10/12
PB - bioRxiv
DO - 10.64898/2026.10.12.753798
UR - https://www.biorxiv.org/content/10.64898/2026.10.12.753798v1
ER -